Loading…

Effect of 5-aminolevulinic acid on the expression of carcinogenesis-related proteins in cultured primary hepatocytes

Acute intermittent porphyria (AIP) is a heme pathway disorder caused by a decrease in the activity and synthesis of porphobilinogen deaminase. Thus, the first heme precursor 5-aminolevulinic acid (ALA) accumulates in the liver. Reactive oxygen species (ROS) resulting from ALA oxidation may be correl...

Full description

Saved in:
Bibliographic Details
Published in:Molecular biology reports 2018-12, Vol.45 (6), p.2801-2809
Main Authors: Menezes, P. R., González, C. B., DeSouza, A. O., Maria, D. A., Onuki, J.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c438t-6cf8b15518653a1323cb1f7f14d1959acf977b582a1f7977b2f67ad6b88964943
cites cdi_FETCH-LOGICAL-c438t-6cf8b15518653a1323cb1f7f14d1959acf977b582a1f7977b2f67ad6b88964943
container_end_page 2809
container_issue 6
container_start_page 2801
container_title Molecular biology reports
container_volume 45
creator Menezes, P. R.
González, C. B.
DeSouza, A. O.
Maria, D. A.
Onuki, J.
description Acute intermittent porphyria (AIP) is a heme pathway disorder caused by a decrease in the activity and synthesis of porphobilinogen deaminase. Thus, the first heme precursor 5-aminolevulinic acid (ALA) accumulates in the liver. Reactive oxygen species (ROS) resulting from ALA oxidation may be correlated to a higher incidence of hepatocellular carcinoma (HCC) in AIP patients. However, the molecular mechanisms of this relationship have not been thoroughly elucidated to date. In this study, we investigated the effect of increasing levels of ALA on the expression of proteins related to DNA repair, oxidative stress, apoptosis, proliferation and lipid metabolism. Primary rat hepatocytes were isolated by the collagenase perfusion method, lipoperoxidation was evaluated by a TBA fluorimetric assay and Western blotting was used to assess protein abundance. The data showed that ALA treatment promoted a dose-dependent increase of p53 expression, downregulation of Bcl-2, HMG-CoA reductase and OGG1 and an increase in lipoperoxidation. There was no alteration in the expression of the transcription factor NF-κB, catalase and superoxide dismutase. ALA oxidation products induced protein regulation patterns, suggesting the interconnection of cellular processes, such as the intrinsic pathway of apoptosis, redox homeostasis, cell proliferation, lipid metabolism and DNA repair. This study helps to elucidate the molecular mechanisms of hepatotoxicity mediated by ALA pro-oxidant effects and supports the hypothesis that ALA accumulation correlates with a higher incidence of hepatic carcinogenic events.
doi_str_mv 10.1007/s11033-018-4367-5
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2103990150</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2103990150</sourcerecordid><originalsourceid>FETCH-LOGICAL-c438t-6cf8b15518653a1323cb1f7f14d1959acf977b582a1f7977b2f67ad6b88964943</originalsourceid><addsrcrecordid>eNp1kMFO3DAQhq0KxG6BB-gFWeLs1hPHsXNEq6UgIfUCZ8txxmCUTRbbqdi3r7e7lFNPtsff_DP6CPkG_Dtwrn4kAC4E46BZLRrF5BeyBKkEq1ulT8iSCw6s1hIW5GtKr5zzGpQ8IwvBK9BCVkuS196jy3TyVDK7CeM04O95CGNw1LrQ02mk-QUpvm8jphTKs6DORlfQZxwxhcQiDjZjT7dxyhjGRMNI3TzkOf4tho2NO_qCW5snt8uYLsipt0PCy-N5Tp5u14-rO_bw6-f96uaBuVrozBrndQdSgm6ksCAq4TrwykPdQytb63yrVCd1ZUt1f618o2zfdFq3Td3W4pxcH3LLYm8zpmxepzmOZaSpirm25SB5oeBAuTilFNGb48oGuNl7NgfPpng2e89Glp6rY_LcbbD_1_EhtgDVAUjla3zG-Dn6_6l_AApxiVc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2103990150</pqid></control><display><type>article</type><title>Effect of 5-aminolevulinic acid on the expression of carcinogenesis-related proteins in cultured primary hepatocytes</title><source>Springer Nature</source><creator>Menezes, P. R. ; González, C. B. ; DeSouza, A. O. ; Maria, D. A. ; Onuki, J.</creator><creatorcontrib>Menezes, P. R. ; González, C. B. ; DeSouza, A. O. ; Maria, D. A. ; Onuki, J.</creatorcontrib><description>Acute intermittent porphyria (AIP) is a heme pathway disorder caused by a decrease in the activity and synthesis of porphobilinogen deaminase. Thus, the first heme precursor 5-aminolevulinic acid (ALA) accumulates in the liver. Reactive oxygen species (ROS) resulting from ALA oxidation may be correlated to a higher incidence of hepatocellular carcinoma (HCC) in AIP patients. However, the molecular mechanisms of this relationship have not been thoroughly elucidated to date. In this study, we investigated the effect of increasing levels of ALA on the expression of proteins related to DNA repair, oxidative stress, apoptosis, proliferation and lipid metabolism. Primary rat hepatocytes were isolated by the collagenase perfusion method, lipoperoxidation was evaluated by a TBA fluorimetric assay and Western blotting was used to assess protein abundance. The data showed that ALA treatment promoted a dose-dependent increase of p53 expression, downregulation of Bcl-2, HMG-CoA reductase and OGG1 and an increase in lipoperoxidation. There was no alteration in the expression of the transcription factor NF-κB, catalase and superoxide dismutase. ALA oxidation products induced protein regulation patterns, suggesting the interconnection of cellular processes, such as the intrinsic pathway of apoptosis, redox homeostasis, cell proliferation, lipid metabolism and DNA repair. This study helps to elucidate the molecular mechanisms of hepatotoxicity mediated by ALA pro-oxidant effects and supports the hypothesis that ALA accumulation correlates with a higher incidence of hepatic carcinogenic events.</description><identifier>ISSN: 0301-4851</identifier><identifier>EISSN: 1573-4978</identifier><identifier>DOI: 10.1007/s11033-018-4367-5</identifier><identifier>PMID: 30218352</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Aminolevulinic acid ; Aminolevulinic Acid - pharmacology ; Animal Anatomy ; Animal Biochemistry ; Animals ; Apoptosis ; Apoptosis - drug effects ; Bcl-2 protein ; Biomedical and Life Sciences ; Carcinogenesis ; Carcinogenesis - drug effects ; Carcinoma, Hepatocellular - metabolism ; Catalase ; Cell proliferation ; Cell Proliferation - drug effects ; Collagen ; Collagenase ; DNA repair ; DNA Repair - drug effects ; Gene Expression Regulation - drug effects ; Heme ; Hepatocellular carcinoma ; Hepatocytes ; Hepatocytes - drug effects ; Hepatotoxicity ; Histology ; Homeostasis ; Hydroxymethylbilane synthase ; Hydroxymethylglutaryl-CoA reductase ; Life Sciences ; Lipid metabolism ; Lipid Metabolism - drug effects ; Liver - drug effects ; Liver cancer ; Liver Neoplasms - metabolism ; Male ; Metabolism ; Molecular modelling ; Morphology ; NF-κB protein ; OGG1 protein ; Oxidation ; Oxidative stress ; Oxidative Stress - drug effects ; Porphyria ; Primary Cell Culture ; Rats ; Rats, Wistar ; Reactive Oxygen Species ; Short Communication ; Superoxide Dismutase ; Western blotting</subject><ispartof>Molecular biology reports, 2018-12, Vol.45 (6), p.2801-2809</ispartof><rights>Springer Nature B.V. 2018</rights><rights>Molecular Biology Reports is a copyright of Springer, (2018). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c438t-6cf8b15518653a1323cb1f7f14d1959acf977b582a1f7977b2f67ad6b88964943</citedby><cites>FETCH-LOGICAL-c438t-6cf8b15518653a1323cb1f7f14d1959acf977b582a1f7977b2f67ad6b88964943</cites><orcidid>0000-0001-5343-8848 ; 0000-0002-0527-5877 ; 0000-0001-7676-9551 ; 0000-0002-5629-1594 ; 0000-0001-6025-7500</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30218352$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Menezes, P. R.</creatorcontrib><creatorcontrib>González, C. B.</creatorcontrib><creatorcontrib>DeSouza, A. O.</creatorcontrib><creatorcontrib>Maria, D. A.</creatorcontrib><creatorcontrib>Onuki, J.</creatorcontrib><title>Effect of 5-aminolevulinic acid on the expression of carcinogenesis-related proteins in cultured primary hepatocytes</title><title>Molecular biology reports</title><addtitle>Mol Biol Rep</addtitle><addtitle>Mol Biol Rep</addtitle><description>Acute intermittent porphyria (AIP) is a heme pathway disorder caused by a decrease in the activity and synthesis of porphobilinogen deaminase. Thus, the first heme precursor 5-aminolevulinic acid (ALA) accumulates in the liver. Reactive oxygen species (ROS) resulting from ALA oxidation may be correlated to a higher incidence of hepatocellular carcinoma (HCC) in AIP patients. However, the molecular mechanisms of this relationship have not been thoroughly elucidated to date. In this study, we investigated the effect of increasing levels of ALA on the expression of proteins related to DNA repair, oxidative stress, apoptosis, proliferation and lipid metabolism. Primary rat hepatocytes were isolated by the collagenase perfusion method, lipoperoxidation was evaluated by a TBA fluorimetric assay and Western blotting was used to assess protein abundance. The data showed that ALA treatment promoted a dose-dependent increase of p53 expression, downregulation of Bcl-2, HMG-CoA reductase and OGG1 and an increase in lipoperoxidation. There was no alteration in the expression of the transcription factor NF-κB, catalase and superoxide dismutase. ALA oxidation products induced protein regulation patterns, suggesting the interconnection of cellular processes, such as the intrinsic pathway of apoptosis, redox homeostasis, cell proliferation, lipid metabolism and DNA repair. This study helps to elucidate the molecular mechanisms of hepatotoxicity mediated by ALA pro-oxidant effects and supports the hypothesis that ALA accumulation correlates with a higher incidence of hepatic carcinogenic events.</description><subject>Aminolevulinic acid</subject><subject>Aminolevulinic Acid - pharmacology</subject><subject>Animal Anatomy</subject><subject>Animal Biochemistry</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Bcl-2 protein</subject><subject>Biomedical and Life Sciences</subject><subject>Carcinogenesis</subject><subject>Carcinogenesis - drug effects</subject><subject>Carcinoma, Hepatocellular - metabolism</subject><subject>Catalase</subject><subject>Cell proliferation</subject><subject>Cell Proliferation - drug effects</subject><subject>Collagen</subject><subject>Collagenase</subject><subject>DNA repair</subject><subject>DNA Repair - drug effects</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Heme</subject><subject>Hepatocellular carcinoma</subject><subject>Hepatocytes</subject><subject>Hepatocytes - drug effects</subject><subject>Hepatotoxicity</subject><subject>Histology</subject><subject>Homeostasis</subject><subject>Hydroxymethylbilane synthase</subject><subject>Hydroxymethylglutaryl-CoA reductase</subject><subject>Life Sciences</subject><subject>Lipid metabolism</subject><subject>Lipid Metabolism - drug effects</subject><subject>Liver - drug effects</subject><subject>Liver cancer</subject><subject>Liver Neoplasms - metabolism</subject><subject>Male</subject><subject>Metabolism</subject><subject>Molecular modelling</subject><subject>Morphology</subject><subject>NF-κB protein</subject><subject>OGG1 protein</subject><subject>Oxidation</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - drug effects</subject><subject>Porphyria</subject><subject>Primary Cell Culture</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Reactive Oxygen Species</subject><subject>Short Communication</subject><subject>Superoxide Dismutase</subject><subject>Western blotting</subject><issn>0301-4851</issn><issn>1573-4978</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kMFO3DAQhq0KxG6BB-gFWeLs1hPHsXNEq6UgIfUCZ8txxmCUTRbbqdi3r7e7lFNPtsff_DP6CPkG_Dtwrn4kAC4E46BZLRrF5BeyBKkEq1ulT8iSCw6s1hIW5GtKr5zzGpQ8IwvBK9BCVkuS196jy3TyVDK7CeM04O95CGNw1LrQ02mk-QUpvm8jphTKs6DORlfQZxwxhcQiDjZjT7dxyhjGRMNI3TzkOf4tho2NO_qCW5snt8uYLsipt0PCy-N5Tp5u14-rO_bw6-f96uaBuVrozBrndQdSgm6ksCAq4TrwykPdQytb63yrVCd1ZUt1f618o2zfdFq3Td3W4pxcH3LLYm8zpmxepzmOZaSpirm25SB5oeBAuTilFNGb48oGuNl7NgfPpng2e89Glp6rY_LcbbD_1_EhtgDVAUjla3zG-Dn6_6l_AApxiVc</recordid><startdate>20181201</startdate><enddate>20181201</enddate><creator>Menezes, P. R.</creator><creator>González, C. B.</creator><creator>DeSouza, A. O.</creator><creator>Maria, D. A.</creator><creator>Onuki, J.</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope><orcidid>https://orcid.org/0000-0001-5343-8848</orcidid><orcidid>https://orcid.org/0000-0002-0527-5877</orcidid><orcidid>https://orcid.org/0000-0001-7676-9551</orcidid><orcidid>https://orcid.org/0000-0002-5629-1594</orcidid><orcidid>https://orcid.org/0000-0001-6025-7500</orcidid></search><sort><creationdate>20181201</creationdate><title>Effect of 5-aminolevulinic acid on the expression of carcinogenesis-related proteins in cultured primary hepatocytes</title><author>Menezes, P. R. ; González, C. B. ; DeSouza, A. O. ; Maria, D. A. ; Onuki, J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c438t-6cf8b15518653a1323cb1f7f14d1959acf977b582a1f7977b2f67ad6b88964943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aminolevulinic acid</topic><topic>Aminolevulinic Acid - pharmacology</topic><topic>Animal Anatomy</topic><topic>Animal Biochemistry</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Bcl-2 protein</topic><topic>Biomedical and Life Sciences</topic><topic>Carcinogenesis</topic><topic>Carcinogenesis - drug effects</topic><topic>Carcinoma, Hepatocellular - metabolism</topic><topic>Catalase</topic><topic>Cell proliferation</topic><topic>Cell Proliferation - drug effects</topic><topic>Collagen</topic><topic>Collagenase</topic><topic>DNA repair</topic><topic>DNA Repair - drug effects</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Heme</topic><topic>Hepatocellular carcinoma</topic><topic>Hepatocytes</topic><topic>Hepatocytes - drug effects</topic><topic>Hepatotoxicity</topic><topic>Histology</topic><topic>Homeostasis</topic><topic>Hydroxymethylbilane synthase</topic><topic>Hydroxymethylglutaryl-CoA reductase</topic><topic>Life Sciences</topic><topic>Lipid metabolism</topic><topic>Lipid Metabolism - drug effects</topic><topic>Liver - drug effects</topic><topic>Liver cancer</topic><topic>Liver Neoplasms - metabolism</topic><topic>Male</topic><topic>Metabolism</topic><topic>Molecular modelling</topic><topic>Morphology</topic><topic>NF-κB protein</topic><topic>OGG1 protein</topic><topic>Oxidation</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - drug effects</topic><topic>Porphyria</topic><topic>Primary Cell Culture</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Reactive Oxygen Species</topic><topic>Short Communication</topic><topic>Superoxide Dismutase</topic><topic>Western blotting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Menezes, P. R.</creatorcontrib><creatorcontrib>González, C. B.</creatorcontrib><creatorcontrib>DeSouza, A. O.</creatorcontrib><creatorcontrib>Maria, D. A.</creatorcontrib><creatorcontrib>Onuki, J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Health &amp; Medicine (ProQuest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><jtitle>Molecular biology reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Menezes, P. R.</au><au>González, C. B.</au><au>DeSouza, A. O.</au><au>Maria, D. A.</au><au>Onuki, J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of 5-aminolevulinic acid on the expression of carcinogenesis-related proteins in cultured primary hepatocytes</atitle><jtitle>Molecular biology reports</jtitle><stitle>Mol Biol Rep</stitle><addtitle>Mol Biol Rep</addtitle><date>2018-12-01</date><risdate>2018</risdate><volume>45</volume><issue>6</issue><spage>2801</spage><epage>2809</epage><pages>2801-2809</pages><issn>0301-4851</issn><eissn>1573-4978</eissn><abstract>Acute intermittent porphyria (AIP) is a heme pathway disorder caused by a decrease in the activity and synthesis of porphobilinogen deaminase. Thus, the first heme precursor 5-aminolevulinic acid (ALA) accumulates in the liver. Reactive oxygen species (ROS) resulting from ALA oxidation may be correlated to a higher incidence of hepatocellular carcinoma (HCC) in AIP patients. However, the molecular mechanisms of this relationship have not been thoroughly elucidated to date. In this study, we investigated the effect of increasing levels of ALA on the expression of proteins related to DNA repair, oxidative stress, apoptosis, proliferation and lipid metabolism. Primary rat hepatocytes were isolated by the collagenase perfusion method, lipoperoxidation was evaluated by a TBA fluorimetric assay and Western blotting was used to assess protein abundance. The data showed that ALA treatment promoted a dose-dependent increase of p53 expression, downregulation of Bcl-2, HMG-CoA reductase and OGG1 and an increase in lipoperoxidation. There was no alteration in the expression of the transcription factor NF-κB, catalase and superoxide dismutase. ALA oxidation products induced protein regulation patterns, suggesting the interconnection of cellular processes, such as the intrinsic pathway of apoptosis, redox homeostasis, cell proliferation, lipid metabolism and DNA repair. This study helps to elucidate the molecular mechanisms of hepatotoxicity mediated by ALA pro-oxidant effects and supports the hypothesis that ALA accumulation correlates with a higher incidence of hepatic carcinogenic events.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>30218352</pmid><doi>10.1007/s11033-018-4367-5</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-5343-8848</orcidid><orcidid>https://orcid.org/0000-0002-0527-5877</orcidid><orcidid>https://orcid.org/0000-0001-7676-9551</orcidid><orcidid>https://orcid.org/0000-0002-5629-1594</orcidid><orcidid>https://orcid.org/0000-0001-6025-7500</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0301-4851
ispartof Molecular biology reports, 2018-12, Vol.45 (6), p.2801-2809
issn 0301-4851
1573-4978
language eng
recordid cdi_proquest_journals_2103990150
source Springer Nature
subjects Aminolevulinic acid
Aminolevulinic Acid - pharmacology
Animal Anatomy
Animal Biochemistry
Animals
Apoptosis
Apoptosis - drug effects
Bcl-2 protein
Biomedical and Life Sciences
Carcinogenesis
Carcinogenesis - drug effects
Carcinoma, Hepatocellular - metabolism
Catalase
Cell proliferation
Cell Proliferation - drug effects
Collagen
Collagenase
DNA repair
DNA Repair - drug effects
Gene Expression Regulation - drug effects
Heme
Hepatocellular carcinoma
Hepatocytes
Hepatocytes - drug effects
Hepatotoxicity
Histology
Homeostasis
Hydroxymethylbilane synthase
Hydroxymethylglutaryl-CoA reductase
Life Sciences
Lipid metabolism
Lipid Metabolism - drug effects
Liver - drug effects
Liver cancer
Liver Neoplasms - metabolism
Male
Metabolism
Molecular modelling
Morphology
NF-κB protein
OGG1 protein
Oxidation
Oxidative stress
Oxidative Stress - drug effects
Porphyria
Primary Cell Culture
Rats
Rats, Wistar
Reactive Oxygen Species
Short Communication
Superoxide Dismutase
Western blotting
title Effect of 5-aminolevulinic acid on the expression of carcinogenesis-related proteins in cultured primary hepatocytes
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T10%3A57%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%205-aminolevulinic%20acid%20on%20the%20expression%20of%20carcinogenesis-related%20proteins%20in%20cultured%20primary%20hepatocytes&rft.jtitle=Molecular%20biology%20reports&rft.au=Menezes,%20P.%20R.&rft.date=2018-12-01&rft.volume=45&rft.issue=6&rft.spage=2801&rft.epage=2809&rft.pages=2801-2809&rft.issn=0301-4851&rft.eissn=1573-4978&rft_id=info:doi/10.1007/s11033-018-4367-5&rft_dat=%3Cproquest_cross%3E2103990150%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c438t-6cf8b15518653a1323cb1f7f14d1959acf977b582a1f7977b2f67ad6b88964943%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2103990150&rft_id=info:pmid/30218352&rfr_iscdi=true